Invitrogen™ Human SPRED1 Synthetic Peptide

Réf. : 15378950
141.00€

Synthetic Peptide

Gene ID (Entrez)
161742
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q7Z699
Nom usuel
Human SPRED1
Marque
Invitrogen™

Spred1 Synthetic Peptide, PEP-0738, from Invitrogen.

The Ras-MAP kinase pathway is essential for the differentiation of neuronal cells and myocytes; it is inhibited by Spred1, a member of the Sprouty family of proteins. Spred1 acts by suppressing the phosphorylation and activation of Raf. The Spred proteins have also been implicated in the negative feedback regulation of FGF signaling in embryogenesis and angiogenesis. Further studies have shown that expression levels of Spred1 and Spred2 proteins are inversely correlated with the incidence of tumor invasion and metastasis in human hepatocellular carcinoma (HHC), suggesting that these proteins could be useful as prognostic factors and therapeutic targets in HCC. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS).
Gene ID (Entrez)
161742
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q7Z699
Nom usuel
Human SPRED1
Concentration
200 μg/mL
Contenu et stockage
-20°C
Description
Synthetic Peptide
Format
Liquid
Formule
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)
Blocking Assay, Control
Symbole de gène(s)
SPRED1
Lyophilisé
No
Conservateur
0.02% sodium azide
Type de produit
Peptide
Quantité
50 μg
État réglementaire
RUO - research use only
Tampon de stockage
PBS